世界の潰瘍性大腸炎治療薬市場2020-2025:経口、注射

LP Informationが発行した調査報告書(LPI21MA04089)
◆英語タイトル:Global Drug for Ulcerative Colitis Market Growth 2020-2025
◆商品コード:LPI21MA04089
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年1月(※2024年版があります。お問い合わせください。)
◆ページ数:133
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

「潰瘍性大腸炎治療薬の世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、経口、注射など、用途別には、病院、ドラッグストアなどに区分してまとめた調査レポートです。潰瘍性大腸炎治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・潰瘍性大腸炎治療薬の世界市場概要(サマリー)
・潰瘍性大腸炎治療薬の企業別販売量・売上
・潰瘍性大腸炎治療薬の企業別市場シェア
・潰瘍性大腸炎治療薬の世界市場規模 2015年-2020年:種類別(経口、注射)
・潰瘍性大腸炎治療薬の世界市場規模 2015年-2020年:用途別(病院、ドラッグストア)
・潰瘍性大腸炎治療薬の米州市場規模(アメリカ、カナダ、メキシコなど)
・潰瘍性大腸炎治療薬のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・潰瘍性大腸炎治療薬の欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・潰瘍性大腸炎治療薬の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・潰瘍性大腸炎治療薬市場の成長要因・課題・動向
・潰瘍性大腸炎治療薬の世界市場予測 2021年-2025年
・潰瘍性大腸炎治療薬の米州市場予測(アメリカ、カナダ、メキシコなど)
・潰瘍性大腸炎治療薬のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・潰瘍性大腸炎治療薬の欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・潰瘍性大腸炎治療薬の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・潰瘍性大腸炎治療薬の世界市場予測:種類別(経口、注射)
・潰瘍性大腸炎治療薬の世界市場予測:用途別(病院、ドラッグストア)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Drug for Ulcerative Colitis market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Drug for Ulcerative Colitis business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Drug for Ulcerative Colitis market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Drug for Ulcerative Colitis, covering the supply chain analysis, impact assessment to the Drug for Ulcerative Colitis market size growth rate in several scenarios, and the measures to be undertaken by Drug for Ulcerative Colitis companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Oral
Injection

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Drugs Stores

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Johnson & Johnson.
InDeX Pharmaceuticals
AbbVie
Roche
Warner Chilcott
Takeda Pharmaceuticals
Ferring Pharmaceuticals
Salix Pharmaceuticals/Santarus
Pfizer
Takeda

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Drug for Ulcerative Colitis consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Drug for Ulcerative Colitis market by identifying its various subsegments.
Focuses on the key global Drug for Ulcerative Colitis manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Drug for Ulcerative Colitis with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Drug for Ulcerative Colitis submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug for Ulcerative Colitis Consumption 2015-2025
2.1.2 Drug for Ulcerative Colitis Consumption CAGR by Region
2.2 Drug for Ulcerative Colitis Segment by Type
2.2.1 Oral
2.2.2 Injection
2.3 Drug for Ulcerative Colitis Consumption by Type
2.3.1 Global Drug for Ulcerative Colitis Consumption Market Share by Type (2015-2020)
2.3.2 Global Drug for Ulcerative Colitis Revenue and Market Share by Type (2015-2020)
2.3.3 Global Drug for Ulcerative Colitis Sale Price by Type (2015-2020)
2.4 Drug for Ulcerative Colitis Segment by Application
2.4.1 Hospital
2.4.2 Drugs Stores
2.5 Drug for Ulcerative Colitis Consumption by Application
2.5.1 Global Drug for Ulcerative Colitis Consumption Market Share by Type (2015-2020)
2.5.2 Global Drug for Ulcerative Colitis Value and Market Share by Type (2015-2020)
2.5.3 Global Drug for Ulcerative Colitis Sale Price by Type (2015-2020)

3 Global Drug for Ulcerative Colitis by Company
3.1 Global Drug for Ulcerative Colitis Sales Market Share by Company
3.1.1 Global Drug for Ulcerative Colitis Sales by Company (2018-2020)
3.1.2 Global Drug for Ulcerative Colitis Sales Market Share by Company (2018-2020)
3.2 Global Drug for Ulcerative Colitis Revenue Market Share by Company
3.2.1 Global Drug for Ulcerative Colitis Revenue by Company (2018-2020)
3.2.2 Global Drug for Ulcerative Colitis Revenue Market Share by Company (2018-2020)
3.3 Global Drug for Ulcerative Colitis Sale Price by Company
3.4 Global Drug for Ulcerative Colitis Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Drug for Ulcerative Colitis Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Drug for Ulcerative Colitis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Drug for Ulcerative Colitis by Regions
4.1 Drug for Ulcerative Colitis by Regions
4.2 Americas Drug for Ulcerative Colitis Consumption Growth
4.3 APAC Drug for Ulcerative Colitis Consumption Growth
4.4 Europe Drug for Ulcerative Colitis Consumption Growth
4.5 Middle East & Africa Drug for Ulcerative Colitis Consumption Growth

5 Americas
5.1 Americas Drug for Ulcerative Colitis Consumption by Countries
5.1.1 Americas Drug for Ulcerative Colitis Consumption by Countries (2015-2020)
5.1.2 Americas Drug for Ulcerative Colitis Value by Countries (2015-2020)
5.2 Americas Drug for Ulcerative Colitis Consumption by Type
5.3 Americas Drug for Ulcerative Colitis Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Drug for Ulcerative Colitis Consumption by Regions
6.1.1 APAC Drug for Ulcerative Colitis Consumption by Regions (2015-2020)
6.1.2 APAC Drug for Ulcerative Colitis Value by Regions (2015-2020)
6.2 APAC Drug for Ulcerative Colitis Consumption by Type
6.3 APAC Drug for Ulcerative Colitis Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Drug for Ulcerative Colitis by Countries
7.1.1 Europe Drug for Ulcerative Colitis Consumption by Countries (2015-2020)
7.1.2 Europe Drug for Ulcerative Colitis Value by Countries (2015-2020)
7.2 Europe Drug for Ulcerative Colitis Consumption by Type
7.3 Europe Drug for Ulcerative Colitis Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Drug for Ulcerative Colitis by Countries
8.1.1 Middle East & Africa Drug for Ulcerative Colitis Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Drug for Ulcerative Colitis Value by Countries (2015-2020)
8.2 Middle East & Africa Drug for Ulcerative Colitis Consumption by Type
8.3 Middle East & Africa Drug for Ulcerative Colitis Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Drug for Ulcerative Colitis Distributors
10.3 Drug for Ulcerative Colitis Customer

11 Global Drug for Ulcerative Colitis Market Forecast
11.1 Global Drug for Ulcerative Colitis Consumption Forecast (2021-2025)
11.2 Global Drug for Ulcerative Colitis Forecast by Regions
11.2.1 Global Drug for Ulcerative Colitis Forecast by Regions (2021-2025)
11.2.2 Global Drug for Ulcerative Colitis Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Drug for Ulcerative Colitis Forecast by Type
11.8 Global Drug for Ulcerative Colitis Forecast by Application

12 Key Players Analysis
12.1 Johnson & Johnson.
12.1.1 Company Information
12.1.2 Drug for Ulcerative Colitis Product Offered
12.1.3 Johnson & Johnson. Drug for Ulcerative Colitis Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Johnson & Johnson. Latest Developments
12.2 InDeX Pharmaceuticals
12.2.1 Company Information
12.2.2 Drug for Ulcerative Colitis Product Offered
12.2.3 InDeX Pharmaceuticals Drug for Ulcerative Colitis Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 InDeX Pharmaceuticals Latest Developments
12.3 AbbVie
12.3.1 Company Information
12.3.2 Drug for Ulcerative Colitis Product Offered
12.3.3 AbbVie Drug for Ulcerative Colitis Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 AbbVie Latest Developments
12.4 Roche
12.4.1 Company Information
12.4.2 Drug for Ulcerative Colitis Product Offered
12.4.3 Roche Drug for Ulcerative Colitis Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Roche Latest Developments
12.5 Warner Chilcott
12.5.1 Company Information
12.5.2 Drug for Ulcerative Colitis Product Offered
12.5.3 Warner Chilcott Drug for Ulcerative Colitis Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Warner Chilcott Latest Developments
12.6 Takeda Pharmaceuticals
12.6.1 Company Information
12.6.2 Drug for Ulcerative Colitis Product Offered
12.6.3 Takeda Pharmaceuticals Drug for Ulcerative Colitis Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Takeda Pharmaceuticals Latest Developments
12.7 Ferring Pharmaceuticals
12.7.1 Company Information
12.7.2 Drug for Ulcerative Colitis Product Offered
12.7.3 Ferring Pharmaceuticals Drug for Ulcerative Colitis Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Ferring Pharmaceuticals Latest Developments
12.8 Salix Pharmaceuticals/Santarus
12.8.1 Company Information
12.8.2 Drug for Ulcerative Colitis Product Offered
12.8.3 Salix Pharmaceuticals/Santarus Drug for Ulcerative Colitis Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Salix Pharmaceuticals/Santarus Latest Developments
12.9 Pfizer
12.9.1 Company Information
12.9.2 Drug for Ulcerative Colitis Product Offered
12.9.3 Pfizer Drug for Ulcerative Colitis Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Pfizer Latest Developments
12.10 Takeda
12.10.1 Company Information
12.10.2 Drug for Ulcerative Colitis Product Offered
12.10.3 Takeda Drug for Ulcerative Colitis Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Takeda Latest Developments

13 Research Findings and Conclusion



【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の潰瘍性大腸炎治療薬市場2020-2025:経口、注射(Global Drug for Ulcerative Colitis Market Growth 2020-2025)]についてメールでお問い合わせはこちらでお願いします。